Biotech Stock News (MNKD) (SNY) (DVAX) (GSK) (AFFX) (TMO)

Mannkind Corporation (NASDAQ:MNKD) On Tuesday January 5th, 2016 shares of Mannkind fell by more than 48% after it was announced that the collaboration agreement by Sanofi (NYSE:SNY) had been terminated. This agreement was formed way back in 2014 where Sanofi made an upfront payment of $150 million. Sanofi was to take global rights for Afrezza, … Read more

MannKind (MNKD) Stock: What Investors Need To Know About Afrezza

MannKind Corporation (NASDAQ: MNKD) MannKind has had a tough time in the market recently, however, the rough time isn’t likely to last forever. There are several things that investors should keep in mind with regard to Afrezza when thinking about MNKD. Here they are… Insurance Coverage Is Gearing Up First and foremost, investors have been … Read more

MannKind Corporation (MNKD): The Battle Rages On

MannKind Corporation (NASDAQ: MNKD) For me, one of the most interesting stocks in biotech is MannKind Corporation. That’s because throughout the past year, MNKD has been the stage for one of the biggest battles between the bulls and the bears that I’ve seen in quite some time. More importantly, there’s a level of validity to … Read more

MannKind (MNKD) Announces Additional Afrezza Manufacturing

MannKind Corporation (NASDAQ: MNKD) MannKind has been taking hit after hit in the market. Unfortunately, the stock has seen decline after decline for nearly two months based on underwhelming sales of Afrezza. However, the company is increasing production of the inhaled insulin; insinuating that it is expecting to see an increase in sales relatively soon … Read more

MannKind Corporation (MNKD) Stock | Why Today’s Declines Are Exciting For Bulls

MannKind Corporation¬†(NASDAQ: MNKD) MannKind Corporation is a very interesting stock to watch. It is one of the few that can generate big excitement for bulls during downtrends. As a matter of fact, MNKD is currently (11:33) trading at $5.26 per share after a loss of 7.07% so far today. Nonetheless, a quick search on StockTwits … Read more

C.N.A. Stocks Today | MannKind Corporation (MNKD) | Synergy Pharmaceuticals (SGYP) | Catalyst Pharmaceutical Partners (CPRX)

When I created CNA Finance, I decided that I would talk about upcoming catalysts, notable movements, and alpha opportunities in the market…that’s where CNA came from. So, I thought it would be a good idea to write a post every day that points out an upcoming catalyst, a stock with notable movements, and an alpha … Read more

MannKind (MNKD) Stock | Why Longs Don’t Care About Declines

MannKind Corporation (NASDAQ: MNKD) If you follow my work here or elsewhere, you know that MannKind is one of my favorite stocks to follow. Aside from the debate revolving around the stock’s ability to grow, I’m intrigued by the fact that this company has come up with a way to deliver insulin to the body … Read more

MannKind Corporation (MNKD) Stock Should Be In Your Portfolio | Here’s Why!

MannKind Corporation (NASDAQ: MNKD) MannKind has been the talk of the town in the healthcare sector for quite some time. It’s pretty rare when a stock stays in the top ten on the healthcare heat map on Stock Twits for more than a month; but MannKind has been there for about three months now. There’s … Read more

Biotech Stocks Presenting Opportunity | Synergy Pharmaceuticals Inc (SGYP) | MannKind Corporation (MNKD) | Gilead Sciences (GILD) | BioMarin Pharmaceutical (BMRN)

Looking into the biotech market today, we’re seeing a sea of red. However, every time we have a bad day, we start to see great opportunities; and that’s no different today. I’ve dug up a few stocks in biotech that I believe to be great opportunities. Here they are… Synergy Pharmaceuticals Is Pulling Back, But … Read more